Europe is not happy with President Trump’s demand that drug manufacturers provide U.S. consumers with equitable pricing.
If President Trump will no longer permit Americans to pay the research production costs for pharmaceutical companies through high prices, essentially subsiding pharmaceutical costs for the world, then Rx companies will have to increase their prices throughout Europe. This is making the Europeans very unhappy.
(Bloomberg Businessweek) — For the past few years, Swiss oncologist Christoph Renner has treated blood cancer patients with Lunsumio, a new drug that helps the immune system recognize and destroy malignant cells. Then, last summer, Renner got an email from Roche Holding AG, Lunsumio’s manufacturer, informing him the treatment would no longer be available in Switzerland because health insurers there wouldn’t pay for the infusions. “You see…




